Ketamine, Esketamine, and A New Generation of Antidepressants.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 2, p. 54, doi. 10.3928/00485713-20200113-02
- By:
- Publication type:
- Article
Works matching IS 00485713 AND DT 2020 AND VI 50 AND IP 2
Results: 8
1
2
Comparative Efficacy of Ketamine in Treatment-Resistant Depression.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 2, p. 62, doi. 10.3928/00485713-20200113-01
- By:
- Publication type:
- Article
3
Neurobiological Mechanisms of Ketamine: Depression, Suicide, Trauma, and Chronic Stress Pathologies.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 2, p. 48, doi. 10.3928/00485713-20200109-02
- By:
- Publication type:
- Article
4
Development of Ketamine Administration as a Treatment for Chronic PTSD.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 2, p. 68, doi. 10.3928/00485713-20200109-01
- By:
- Publication type:
- Article
5
The Evidence for Ketamine in Mood Disorders.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
6
Benzodiazepines and the Risk of Alzheimer's Disease: Association or Protopathic Bias?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
7
Treating Depression and Suicidality in Huntington's Disease.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 2, p. 85, doi. 10.3928/00485713-20200107-01
- By:
- Publication type:
- Article
8
Affective Symptoms in a Patient with Parkinson's Disease and Alkaptonuria.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 2, p. 81, doi. 10.3928/00485713-20200106-01
- By:
- Publication type:
- Article